Jeremy Kasdin
Join Remy Blaire and Paul Romness, President and CEO of OS Therapies as Romness takes us through his companies journey from its inception to its eventual listing on the NYSE (OSTX). Romness explains how the technology manufactured by OS Therapies has created optimism for cancer patients around the world dealing with chemotherapy.
For more information on OS Therapies, visit:
